eISSN: 2299-0054
ISSN: 1895-4588
Videosurgery and Other Miniinvasive Techniques
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2022
vol. 17
 
Share:
Share:
Review paper

Perioperative carbohydrate loading in patients undergoing one-day surgery. A systematic review of randomized controlled trials

Jakub Kukliński
1
,
Karol P. Steckiewicz
1
,
Radosław Owczuk
1

1.
Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland
Videosurgery Miniinv 2022; 17 (3): 457–466
Online publish date: 2022/06/19
Article file
Get citation
 
PlumX metrics:
 

Introduction

One of many aspects of Enhanced Recovery After Surgery protocols (ERAS) is perioperative nutrition and fluid management. Preoperative fasting and surgical injury increases insulin resistance leading to postoperative hyperglycaemia and further complications, such as impaired wound healing. This lengthens hospital stay [1]. However those detrimental metabolic effects can be alleviated to some degree with preoperative administration of a carbohydrate-rich drink [2], which is recommended by both ERAS and ESPEN guidelines [3, 4]. Postoperative nausea and vomiting is another factor known for delaying discharge after surgery, fortunately it can be lessened with a carbohydrate rich drink as well [5, 6]. The carbohydrate drink also improves general well-being after surgery [6, 7].

There are four meta-analyses assessing benefits of the preoperative carbohydrate drink [811], each proving that carbohydrate loading reduces length of hospital stay. However two of them, including the most recent one, show no difference compared to placebo [10, 11]. We have chosen to focus on day-care surgery to take a closer look on secondary outcomes as those previously mentioned reviews were inconclusive in that regard.

Aim

The aim of this review was to determine how preoperative carbohydrate treatment impacts on recovery after elective ambulatory surgery compared to placebo.

Material and methods

Search strategy

The Medline, EBSCO, Scopus, Web of Science (WoS) and Cochrane databases were systematically and comprehensively searched in October 2021 according to Prisma guidelines. The search protocol was prospectively registered in the International prospective register of systematic reviews (PROSPERO) – CRD42021284397. Two reviewers (JK, KPS) independently evaluated each paper. If any disagreement occurred, the third reviewer (RO) was involved. The following data were extracted: title, first author, publication year, number of patients, patient age, sex, body mass index (BMI) and ASA status, inclusion criteria, exclusion criteria, intervention type, allocation, measured outcomes, amount of carbohydrates administered, type of surgery, duration of anaesthesia and surgery.

Search query

The following search query was used to extract articles from databases: ((preoperative or perioperative) and (carbohydrate or CHO or nutricia/nutrition or carbohydrates or maltodextrin or carbohydrate rich) and (drink or treatment or loading or oral or per os or load or administration)) and ((ambulatory or 1-day or elective or outpatient or ambu* or electiv* or fast-track) and (surgery or surgical procedures or procedure or sedation or anesthesia or surg* or general anesthesia)).

Type of studies

We included randomised clinical trials comparing carbohydrate loading with controls in patients over 18 years old undergoing elective ambulatory surgery. Patients undergoing ambulatory surgery receiving clear liquid or nothing were treated as controls.

Inclusion criteria

  • randomised controlled trial,

  • results published in English,

  • participants not younger than 18 years old,

  • general anaesthesia or general anaesthesia combined with regional anaesthesia,

  • any ambulatory or 1-day surgery,

  • elective surgery,

  • subjects received at least 45 g of the carbohydrate drink per os before surgery; controls received other clear liquid or nothing,

  • hospitalisation under 24 h,

  • results published in a reviewed journal.

Exclusion criteria

  • not fulfilling inclusion criteria,

  • basic science research,

  • single-arm studies.

Main outcome

Comparison of the effectiveness of preoperative oral carbohydrate and fasting.

Additional outcomes

  1. Metabolic effect

  2. Impact on fatigue and general well-being

  3. Impact on nausea and vomiting

  4. Other outcomes: as defined and measured by trials’ authors.

Results

Search results

Databases yielded 3467 results, from those 2385 were screened for eligibility criteria based on the titles which gave 240 papers. Those were screened for eligibility criteria based on abstracts which have left 74 papers which were read in full text. After careful consideration against inclusion criteria, 6 papers were included in the review. Prisma flow diagram presents study search in detail (Figure 1).

Figure 1

Prisma flow diagram

CHO – carbohydrates, LOS – length of stay, RCT – randomised controlled trial, WoS – Web of Science.

/f/fulltexts/WIITM/47152/WIITM-17-47152-g001_min.jpg

Characteristics of included studies

Six studies published in 2012–2020 were included in the study [1217]. The studies were conducted in Finland, Turkey, India and Brazil. Majority of patients were females under 50 years old who underwent elective laparoscopic cholecystectomy. Patients had ASA status I–II. In all studies patients received the amount of carbohydrates recommended by ERAS guidelines. The comparator was either fasting placebo or carbohydrates + glycine (GLN group). Detailed characteristics of the studies are presented in Table I.

Table I

Characteristics of included studies

AuthorsLocationGroupParticipantsTotal amount of carbohydrates administered [g]Amount of carbohydrates administered 2 h before surgeryAge (SD) [IQR]Females[%]ASA scaleType of surgeryReference
Helminen et al.Oulu, FinlandCHOn = 57676747 (13)84I–IILaparoscopic cholecystectomy[16]
Fastingn = 560046 (11)77
Singh et al.Chandigarh, IndiaCHOn = 40752543.2 (15.85)85Not reportedLaparoscopic cholecystectomy[17]
Placebon = 400043.72 (15.4)75
Fastingn = 400044.4 (11.45)75
Gök et al.TurkeyCHOn = 211252546.76 (11.1)86I–IILaparoscopic cholecystectomy[15]
Placebon = 210050 (14.24)95
Dock-Nascimento et al.Cuiaba, BrazilControln = 120040 (3.3)100I–IILaparoscopic cholecystectomy[12]
Placebon = 120040 (3.3)100
CHOn = 12752535 (4.1)100
GLNn = 12752543 (3.9)100
Dock-Nascimento et al.Cuiaba, BrazilFastingn = 90042* [18–62]Not reportedI–IILaparoscopic cholecystectomy[13]
CHOn = 107525
GLNn = 97525
Yildiz et al.Ankara, TurkeyCHOn = 301505047.63 (8.83)83I–IILaparoscopic cholecystectomy[14]
Fastingn = 300043.56 (9.82)73

* Age was reported for the whole cohort without distinguishing between groups. ASA – American Society of Anaesthesiologists, CHO – patients receiving carbohydrates, GLN – patients receiving carbohydrates and glycine, IQR – interquartile range, SD – standard deviation.

Quality assessment

We followed Cochrane Collaboration guidelines regarding bias assessment. Each paper was assessed independently by two reviewers. Five databases were searched to ensure that all matching papers were included. In risk of bias assessment, several parameters were included: (I) random sequence generation, (II) allocation concealment, (III) blinding of participants and personnel, (IV) blinding of outcome assessment, (V) incomplete outcome data, (VI) selective reporting, (VII) other potential threats to validity. All studies have met baseline criteria for quality assessment. Typically, there were no issues regarding random sequence generation, however in most cases allocation concealment was not described. Unfortunately majority of the studies were single blinded, or blinding was not reported, also only one study by Helminen et al. published the protocol. We have not found other potential risks within the studies. A summary of biased assessment for each study is presented in Table II.

Table II

Risk of biases in selected studies

AuthorsRandom sequence generationAllocation concealmentBlinding of participants and personnelBlinding of outcome assessmentIncomplete outcome dataSelective reportingOther risksReference
Helminen et al.Low riskLow riskHigh risk – single blindedUnclear –not describedLow risk – balanced dropoutsLow riskLow risk[16]
Singh et al.Low riskUnclear – not describedUnclear – not describedUnclear – not describedUnclear – no information regarding dropoutsUnclear – protocol not publishedLow risk[17]
Gök et al.Low riskUnclear – not describedUnclear – not describedUnclear – not describedUnclear – no information regarding dropoutsUnclear – protocol not publishedLow risk[15]
Dock-Nascimento et al.Low riskUnclear – not describedHigh risk – surgeons were not blindedUnclear – not describedLow risk – balanced dropoutsUnclear – protocol not publishedLow risk[12]
Dock-Nascimento et al.Unclear – not describedUnclear – not describedHigh risk – single blindedUnclear – not describedLow risk – balanced dropoutsUnclear – protocol not publishedLow risk[13]
Yildiz et al.Low riskUnclear – not describedHigh risk – single blindedUnclear – not describedLow risk – no dropoutsUnclear – protocol not publishedLow risk[14]

Thirst and hunger

Three studies examined whether carbohydrate loading can alleviate thirst and hunger [1416]. Helminen et al. used VAS scale (0–100) while Gok et al. and Yildiz et al. measured nausea incidence. In studies by Gök et al. and Yildiz et al., the carbohydrate-rich drink decreased thirst preoperatively or preoperatively and postoperatively. However, Helminen et al. did not support that result (Table III).

Table III

Summary of the results regarding thirst occurrence and intensity

StudyGroupParticipantsThirst pre-op. n (%) Median [IQR]Thirst 0-4 h post-op. n (%) Median [IQR]Thirst 4–12 h post-op. n (%) Median [IQR]Thirst 12–24 h post-op. n (%) Median [IQR]P-valuesReference
Helminen et al.CHOn = 5722 [6–50]41 [20–60]28 [9–61]12 [0–50]0.682[16]
Fastingn = 5640 [8–63]46 [24–70]20 [0–50]10 [0–50]
Gök et al.CHOn = 2112 (57.1%)n/an/an/a0.032[15]
Placebon = 2119 (90.5%)n/an/an/a
Yildiz et al.CHOn = 303 (10%)13 (43.3%)n/a4 (13.3%)< 0.05 (preoperatively) < 0.05 (0–4 h) > 0.05 (12–24 h)[14]
Fastingn = 3026 (86.7%)30 (100%)n/a10 (33.3%)

[i] CHO – patients receiving carbohydrates, IQR – interquartile range, pre-op. – preoperatively, post-op. – postoperatively.

In studies by Gök et al. and Yildiz et al., administration of a carbohydrate-rich drink decreased hunger preoperatively or preoperatively and postoperatively. However, Helminen et al. did not support that result (Table IV).

Table IV

Summary of the results regarding hunger occurrence and intensity

StudyGroupParticipantsHunger pre-operatively n (%) Median [IQR]Hunger 0–4 h post-op. n (%) Median [IQR]Hunger 4–12 h post-op. n (%) Median [IQR]Hunger 12–24 h post-op. n (%) Median [IQR]P-valuesReference
Helminen et al.CHOn = 5726 [2–48]10 [0–34]10 [0–34]0 [0–8]0.529[16]
Fastingn = 5630 [19–55]5 [0–30]5 [0–30]0 [0–11]
Gök et al.CHOn = 219 (42.9)n/an/an/a0.003[15]
Placebon = 2119 (90.5%)n/an/an/a
Yildiz et al.CHOn = 301 (3.3%)5 (16.7%)n/a4 (13.3)< 0.05 (preoperatively) < 0.05 (0–4 h) > 0.05 (12–24 h)[14]
Fastingn = 3019 (63.3%)26 (86.7%)n/a9 (30%)

[i] CHO – patients receiving carbohydrates, GLN – patients receiving carbohydrates and glycine, IQR – interquartile range, pre-op. – preoperatively, post-op. – postoperatively.

Nausea and vomiting

For studies including nausea as examined outcomes [1417], Helminen et al. and Singh et al. used VAS scale while Gök et al. and Yildiz et al. measured nausea incidence. Data are inconsistent as Helminen et al. and Yildiz et al. did not observe any significant changes in nausea intensity. Meanwhile Singh et al. reported that in the early postoperative period nausea was less intensive in the group which received carbohydrates preoperatively, oppositely Gök et al. determined that nausea was more frequent in the pre-op group. Detailed results are presented in Table V.

Table V

Summary of the results regarding nausea occurrence and intensity

StudyGroupParticipantsNausea 0–4 h post-op. n (%) Median [IQR] Mean (SD)Nausea 4–12 h post-op. n (%) Median [IQR] Mean (SD)Nausea 12–24 h post-op. n (%) Median [IQR] Mean (SD)P-valuesReference
Helminen et al.CHOn = 570 [0–14]0 [0–4]0 [0–3]0.476[16]
Fastingn = 560 [0–6]0 [0–10]0 [0–3]
Singh et al.CHOn = 400.65 (0.7)0.7 (0.823)0.25 (0.439)0.001 (0–4 h)
0.066 (4–12 h)
0.357 (12–24 h)
[17]
Placebon = 401.3 (0.853)0.83 (0.636)0.43 (0.501)
Fastingn = 401.23 (1.097)1.05 (0.815)0.35 (0.483)
Gök et al.CHOn = 2121 (100%)15 (71.4%)6 (28.6%)0.048 (0–4 h)
0.014 (4–12 h)
0.093 (12–24 h)
[15]
Placebon = 2116 (76.25%)6 (28.6%)1 (4.8%)
Yildiz et al.CHOn = 3017 (56.7%)n/a1 (3.3%)> 0.05 (4–12 h)
> 0.05 (12–24 h)
[14]
Fastingn = 3017 (56.7%)n/a(6.7%)

[i] CHO – patients receiving carbohydrates, IQR – interquartile range, SD – standard deviation, pre-op. – preoperatively, post-op. – postoperatively.

Singh et al. and Gök et al. examined impact of carbohydrate administration on emesis occurrence [15, 17]. Singh et al. determined that vomiting occurred less frequently only in the first 4 h postoperatively, however this observation was not supported by the study of Gök et al. It seems that pre-op carbohydrate loading does not have a significant impact on vomiting occurrence more than 4 h after surgery. Moreover, Helminen et al. reported that there were no differences regarding need for antiemetics administration between carbohydrates and fasting group (p = 0.84). Results are presented in Table VI.

Table VI

Summary of the results regarding emesis occurrence

StudyGroupParticipantsVomiting 0–4 h post-op. n (%)Vomiting 4–12 h post-op. n (%)Vomiting 12–24 h post-op. n (%)P-valuesReference
Singh et al.CHOn = 407 (17.5%)3 (7.5%)0 (0%)0.0006 (0–4 h)
0.459 (4–12 h)
0.314 (12–24 h)
[17]
Placebon = 4017 (42.5%)5 (12.5%)1 (2.5%)
Fastingn = 4019 (47.5)13 (32.5%)1 (2.5)
Gök et al.CHOn = 2113 (61.9%)7 (33.3%)0 (0%)0.122 (0–4 h)
0.130 (4–12 h)
0.999 (12–24 h)
[15]
Placebon = 217 (33.3%)2 (9.5%)0 (0%)

[i] CHO – patients receiving carbohydrates, IQR – interquartile range, SD – standard deviation, pre-op. – preoperatively, post-op. – postoperatively.

Pain

Two studies included in the analysis determined the effect of carbohydrates administration on the pain level post-operatively [16, 17]. Helminen et al. measured pain with a visual analog scale (VAS; 0–100), Singh et al. also used VAS, however with a span of 0–10. In the study of Helminen et al., no changes between groups had been found. They also did not observe differences in demand for pain medication and opioids between groups (p = 0.94 and p = 0.95, respectively). Contrarily Singh et al. reported that pain intensity was lower in the CHO group in the first 12 h postoperatively. Based on those two studies it cannot be concluded whether the carbohydrate-rich drink administration has beneficial effects on pain alleviation. Detailed results of included studies are presented in Table VII.

Table VII

Summary of the results regarding pain intensity

StudyGroupPain 0–4 h post-op. Median [IQR] Mean (SD)Pain 4–12 h post-op. Median [IQR] Mean (SD)Pain 12–24 h post-op. Median [IQR] Mean (SD)P-valuesReference
Helminen et al.CHO35 [14–38]20 [2–40]20 [8–38]0.012[16]
Fasting30 [11–50]23 [8–40]20 [3–40]
Singh et al.CHO5.75 (1.918)3.53 (1.633)1.95 (0.714)0.001 (0–4 h)
0.005 (4–12 h)
0.223 (12–24 h)
[17]
Placebo7.13 (1.067)4.08 (1.289)2.08 (0.656)
Fasting6.95 (0.959)4.65 (1.442)2.25 (0.809)

[i] CHO – patients receiving carbohydrates, IQR – interquartile range, SD – standard deviation, pre-op. – preoperatively, post-op. – postoperatively.

Tiredness

Two studies included tiredness in their outcomes [14, 16]. Helminen et al. used the VAS scale (0–100), whereas Yildiz et al. measured tiredness incidence. It seems that the carbohydrate-rich drink did not impact tiredness after surgery. Data regarding the preoperative period are inconclusive as studies reported opposite results (Table VIII).

Table VIII

Summary of the results regarding tiredness

StudyGroupParticipantsTiredness pre-operatively n (%) Median [IQR]Tiredness 0–4 h post-op. n (%) Median [IQR]Tiredness 4–12 h post-op. n (%) Median [IQR]Tiredness 12–24 h post-op. n (%) Median [IQR]P-valuesReference
Helminen et al.CHOn = 5730 [10–56]49 [20–70]42 [8–70]20 [4–48]0.582[16]
Fastingn = 5620 [5–46]53 [30–61]40 [10–50]25 [0–46]
Yildiz et al.CHOn = 304 (13.3%)19 (63.3%)n/a9 (42.9%)< 0.05 (preoperatively)
> 0.05
(0–4 h)
> 0.05
(12–24 h)
[14]
Fastingn = 3014 (46.7%)21 (70%)n/a13 (43.3%)

[i] CHO – patients receiving carbohydrates, GLN – patients receiving carbohydrates and glycine, IQR – interquartile range, SD – standard deviation, pre-op. – preoperatively, post-op. – postoperatively.

Impact on metabolism

Three studies measured impact of pre-op carbohydrate loading on glucose and/or insulin levels [12, 13, 16]. In all studies no differences between groups were found (Table IX).

Table IX

Summary of the results regarding pre- and post-operative levels of glucose and insulin

StudyGroupPre-op. glucose [mmol] Mean (SD)Post-op. glucose [mmol] Mean (SD)P-values for glucosePre-op. insulin [IU/ml] Mean (SD)Post-op. [IU/ml] Mean (SD)P-values for insulinReference
Helminen et al.CHO6.0 (1.6)6.4 (1.1)0.1 (preoperative)
0.37 (postoperative)
n/an/an/a[16]
Fasting5.4 (0.5)6.4 (1.1)n/an/an/a
Dock-Nascimento et al.Control4.4 (0.06)6.1 (0.3)0.16 (preoperative)10.6 (2.1)9.7 (2.4)0.17 (preoperative)[12]
Placebo4.3 (0.11)5.8 (0.2)8.1 (1.0)6.4 (0.9)
CHO4.3 (0.2)5.9 (0.3)13.3 (4.5)8.5 (1.2)
GLN4.3 (0.2)5.7 (0.3)9.6 (1.0)9.9 (1.9)
Dock-Nascimento et al.Fasting4.5 (0.1)6.6 (0.2)> 0.05 for all comparisons between groups12.0 (3.2)13.0 (3.6)> 0.05 for all comparisons between groups[13]
CHO4.3 (0.2)6.0 (0.4)18.6 (5.3)8.6 (1.4)
GLN4.3 (0.2)5.4 (0.4)8.0 (0.8)6.5 (0.7)

Other outcomes

Some outcomes have been described only in one study, here we discuss the selected few. Helminen et al. did not observe any significant changes between groups regarding mouth dryness, time to be able to drink, eat, ambulate or discharge [16]. Dock-Nascimento et al. investigated selected biochemical parameters and they found significant differences between the groups in HOMA-IR, albumin, C-reactive protein and interleukin 6 levels [12]. Another study by Dock-Nascimento et al. found that there are no differences in gastric residual volume between groups [13]. Yildiz et al. have found that weakness, malaise and concentration difficulty are less prominent in patients receiving a carbohydrate-rich drink [14].

Discussion

In this review we included 6 studies with a total of 411 patients undergoing elective 1-day surgery. We aimed to determine whether perioperative carbohydrate-rich drink administration may be beneficial in this group. The results are inconclusive as some of the studies had opposite results.

Preoperative carbohydrate treatment is over 20-year-old idea, with first findings reported in the late 1990s [18, 19]. Over the years reduction in length of hospital stay caused by carbohydrate loading was confirmed in several meta-analyses [811]. However the exact mechanism of action remains uncertain as studies provide conflicting data regarding proposed rationale of increasing postoperative insulin sensitivity [811]. We chose to restrict the scope of this review to day-care surgery in order to improve homogeneity, allowing us to focus on outcomes considered as secondary in previous studies. Also, there is a significant gap in knowledge whether carbohydrate loading can be beneficial in relatively healthy individuals who are typically qualified to be 1-day cases. This proved futile as inconsistent findings across all the studies suggest that carbohydrate loading has little to no impact on measured parameters.

The studies included in this review seem to demonstrate that the carbohydrate-rich drink did not have a significant impact on thirst and hunger. Similarly, Li et al. showed inconsistent results regarding hunger. As for thirst, they observed a significant difference when compared to fasting but not when compared to placebo [9]. With postoperative nausea and vomiting being one of the most common side effects of general anaesthesia [20] early findings about carbohydrate treatment seemed promising [21]. However, our results did not support this as no significant differences were found. This is consistent with previous analyses [811] and guidelines [22]. Considering that safe, effective painkillers are readily available and routinely administered during and after general anaesthesia, it is difficult to assess whether carbohydrate loading has any impact on pain response. Consequently, no significant difference in pain response was found. To the best of our knowledge, it is the first comprehensive assessment of such kind. Moreover, carbohydrate loading has no impact on either glucose or insulin levels. This is unexpected as alleviating postoperative insulin resistance was one of reasons to consider preoperative carbohydrate treatment in the first place [2, 18, 23]. Those results fall in line with previous works [811]. Lastly carbohydrate treatment did not affect postoperative tiredness, which is coherent with previous findings [10, 11].

Our work, being a review, is only as good as the included studies and while they met baseline quality criteria, several limitations should be mentioned. The amount of carbohydrates used differs between studies (67–150 g), though all studies fulfilled ERAS guidelines in this matter. Authors used visual analog scales and incidence reporting, as one could expect when working with parameters of such subjective nature. Those methods rely heavily on patients’ compliance, which in itself is a source of discrepancies, even more so considering side effects of general anaesthesia. As for postoperative insulin resistance, none of the studies used hyperinsulinemic-euglycemic clamp method. Considering the short hospital stay there were no follow-up; nonetheless no readmissions were reported.

Interestingly, there seems to be no advantages of using the carbohydrate-rich drink over placebo for several outcomes. Usually artificially flavoured water was used for this purpose. Given the fact that the carbohydrate-rich drink affects neither hydration [24] nor hemodynamic parameters [25], nor causes significant metabolic changes, any beneficial findings could be associated with a psychosomatic effect. However carbohydrates have been proven not to alter mood in any significant way in healthy adults [26]. While current guidelines recommend carbohydrate loading, any clear liquid, with or without carbohydrate content, is allowed for up to 2 h before surgery [3]. This gives an opportunity to pursue a more cost-effective alternative to meticulously manufactured carbohydrate-rich drinks. However, this idea should be further examined and confirmed.

Conclusions

The quality of evidence regarding preoperative carbohydrate loading in patients qualified for one-day case is relatively low. However, it seems that this procedure does not have beneficial effects.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Nygren J. The metabolic effects of fasting and surgery. Best Practice and Research: Clinical Anaesthesiology, 2006. https://pubmed.ncbi.nlm.nih.gov/17080694/ (accessed October 31, 2020).

2 

Ljungqvist O, Nygren J, Thorell A. Modulation of post-operative insulin resistance by pre-operative carbohydrate loading. Proc Nutr Soc 2002; 61: 329-36.

3 

Weimann A, Braga M, Carli F, et al. ESPEN practical guideline: clinical nutrition in surgery. Clin Nutr 2021; 40: 4745-61.

4 

Miller TE, Roche AM, Mythen M. Fluid management and goal-directed therapy as an adjunct to Enhanced Recovery After Surgery (ERAS). Canad J Anesth 2015; 62: 158-68.

5 

Hausel J, Nygren J, Thorell A, et al. Randomized clinical trial of the effects of oral preoperative carbohydrates on postoperative nausea and vomiting after laparoscopic cholecystectomy. Br J Surg 2005; 92: 415-21.

6 

Sarin A, Chen LL, Wick EC. Enhanced recovery after surgery – preoperative fasting and glucose loading – a review. J Surg Oncol 2017; 116: 578-82.

7 

Nygren JTA, Ljungqvist O, Nygren J, et al. Are there any benefits from minimizing fasting and optimization of nutrition and fluid management for patients undergoing day surgery? Curr Opin Anaesthesiol 2007; 20: 540-4.

8 

Awad S, Varadhan KK, Ljungqvist O, Lobo DN. A meta-analysis of randomised controlled trials on preoperative oral carbohydrate treatment in elective surgery. Clin Nutr 2013; 32: 34-44.

9 

Li L, Wang Z, Ying X, et al. Preoperative carbohydrate loading for elective surgery: a systematic review and meta-analysis. Surg Today 2012; 42: 613-24.

10 

Smith MDD, Mccall J, Plank L, et al. Preoperative carbohydrate treatment for enhancing recovery after elective surgery. Cochrane Database Syst Rev 2014; 8: CD009161.

11 

Amer MA, Smith MD, Herbison GP, et al. Network meta-analysis of the effect of preoperative carbohydrate loading on recovery after elective surgery. Br J Surg 2017; 104: 187-97.

12 

Dock-Nascimento DB, De Aguilar-Nascimento JE, Magalhaes Faria MS, et al. Evaluation of the effects of a preoperative 2-hour fast with maltodextrine and glutamine on insulin resistance, acute-phase response, nitrogen balance, and serum glutathione after laparoscopic cholecystectomy: a controlled randomized trial. J Parent Enteral Nutr 2012; 36: 43-52.

13 

Dock-Nascimento DB, Aguilar-Nascimento JE de, Linetzky Waitzberg D. Ingestion of glutamine and maltodextrin two hours preoperatively improves insulin sensitivity after surgery: a randomized, double blind, controlled trial. Rev Col Bras Cir 2012; 39: 449-55.

14 

Yildiz H, Gunal SE, Yilmaz G, Yucel S. Oral carbohydrate supplementation reduces preoperative discomfort in laparoscopic cholecystectomy. J Investig Surg 2013; 26: 89-95.

15 

Gök MA, Kafadar MT, Gok MA, et al. Effects of preoperative oral carbohydrate loading on preoperative and postoperative comfort in patients planned to undergo elective cholecystectomy: a prospective randomized controlled clinical trial. Iran Red Cresc Med J 2020; 22. https://doi.org/10.32592/ircmj.2020.22.11.107.

16 

Helminen H, Branders H, Ohtonen P, Saarnio J. Effect of pre-operative oral carbohydrate loading on recovery after day-case cholecystectomy: a randomised controlled trial. Eur J Anaesthesiol 2019; 36: 605-11.

17 

Singh B, Dahiya D, Bagaria D, et al. Effects of preoperative carbohydrates drinks on immediate postoperative outcome after day care laparoscopic cholecystectomy. Surg Endosc 2015; 29: 3267‐72.

18 

Nygren J, Soop M, Thorell A, et al. Preoperative oral carbohydrate administration reduces postoperative insulin resistance. Clin Nutr 1998; 17: 65-71.

19 

Nygren JO, Thorell A, Soop M, et al. Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery. Am J Physiol 1998; 275: E140-8.

20 

Öbrink E, Jildenstål P, Oddby E, Jakobsson JG. Post-operative nausea and vomiting: update on predicting the probability and ways to minimize its occurrence, with focus on ambulatory surgery. Int J Surg 2015; 15: 100-6.

21 

Hausel J, Nygren J, Thorell A, et al. Randomized clinical trial of the effects of oral preoperative carbohydrates on postoperative nausea and vomiting after laparoscopic cholecystectomy. Br J Surg 2005; 92: 415-21.

22 

Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118: 85-113.

23 

Soop M, Nygren J, Thorell A, et al. Preoperative oral carbohydrate treatment attenuates endogenous glucose release 3 days after surgery. Clin Nutr 2004; 23: 733-41.

24 

Kukliński J, Steckiewicz KP, Sekuła B, et al. The influence of fasting and carbohydrate-enriched drink administration on body water amount and distribution: a volunteer randomized study. Periop Med 2021; 10: 27.

25 

Kukliński J, Steckiewicz KP, Piwowarczyk SP, et al. Effect of carbohydrate-enriched drink compared to fasting on hemodynamics in healthy volunteers. a randomized trial. J Clin Med 2022; 11: 825.

26 

Mantantzis K, Schlaghecken F, Sünram-Lea SI, Maylor EA. Sugar rush or sugar crash? A meta-analysis of carbohydrate effects on mood. Neurosci Biobehav Rev 2019; 101: 45-67.

Copyright: © 2022 Fundacja Videochirurgii This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
  
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.